NFKB1 and irritable bowel syndrome: Nuclear factor‐kappaB (NF‐κB), a pivotal transcriptional regulator of pro‐inflammatory cascades, exhibits sustained activation in chronic immune disorders such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), driving pathological progression (Mukherjee et al. 2024).